Siddhartha S. Mitra, MS PhD
Affiliations: | 2007-2018 | Institute for Stem Cell Biology and Regenerative Medicine | Stanford University School of Medicine, Palo Alto, CA, United States |
| 2018- | Pediatrics (Heme/Onc/BMT) | University of Colorado School of Medicine, Aurora, CO, United States |
Area:
Neural Stem Cells, Glioma Stem CellsWebsite:
https://som.ucdenver.edu/Profiles/Faculty/Profile/27641Google:
"Siddhartha Mitra"Mean distance: 106866
Parents
Sign in to add mentor| Bruce J Nicholson | grad student | 2005 | SUNY Buffalo | |
| (Understanding the crosstalk between receptor and non-receptor tyrosine kinase signal transduction pathways and Cx43 gap junctional communication.) | ||||
| Irving L. Weissman | research scientist | 2010-2018 | Stanford University Medical School (FlyTree) | |
Children
Sign in to add trainee| Allison Cole | research assistant | 2018- | University of Colorado, Denver |
| Suzana Assad Kahn | post-doc | Stanford Medical School | |
| Gregor Hutter | post-doc | 2014-2016 | Stanford Medical School |
| Sharareh Gholamin | post-doc | 2012-2017 | Stanford Medical School |
| Senthil Lakshmanna Chetty | post-doc | 2019-2021 | University of Colorado School of Medicine |
| Joselyn Cruz Cruz | post-doc | 2019-2021 | University of Colorado School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Marquardt V, Theruvath J, Pauck D, et al. (2023) Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation. Journal For Immunotherapy of Cancer. 11 |
| Alimova I, Wang D, Danis E, et al. (2022) Targeting the TP53/MDM2 axis enhances radiation sensitivity in atypical teratoid rhabdoid tumors. International Journal of Oncology. 60 |
| Lakshmanachetty S, Cruz-Cruz J, Hoffmeyer E, et al. (2021) New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs. Cells. 10 |
| Cole AP, Hoffmeyer E, Chetty SL, et al. (2020) Microglia in the Brain Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1273: 197-208 |
| Theruvath J, Sotillo E, Mount CW, et al. (2020) Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors. Nature Medicine |
| Gholamin S, Youssef OA, Rafat M, et al. (2019) Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immunity. 1753425919876690 |
| SoRelle ED, Yecies DW, Liba O, et al. (2019) Spatiotemporal Tracking of Brain-Tumor-Associated Myeloid Cells in Vivo through Optical Coherence Tomography with Plasmonic Labeling and Speckle Modulation. Acs Nano |
| Mohanty S, Yerneni K, Theruvath JL, et al. (2019) Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death & Disease. 10: 36 |
| Majzner RG, Theruvath JL, Nellan A, et al. (2019) CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Hutter G, Theruvath J, Graef CM, et al. (2019) Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America |